Translational Autoimmunity, Volume 6

1. Introduction on Autoimmune Rheumatic Diseases<br>2. Bone health in autoimmune inflammatory rheumatic diseases<br>3. Rheumatic diseases: from bench to bedside<br>4. Rheumatic fever: from pathogenesis to vaccine perspectives<br>5. Changes in future rheumatoid arthritis treatment in the light of Epstein-Barr virus infection<br>6. Rheumatologic diseases: the microbiota-immunity axis in development and treatment<br>7. The diagnostic laboratory tests in rheumatic diseases<br>8. Autoantibody profiling in autoimmune rheumatic diseases: from basic research to clinical use<br>9. Air pollution and rheumatoid arthritis: current knowledge and state-of-the-art<br>10. Advanced therapies for rheumatoid arthritis<br>11. A tolerogenic dendritic cell-based therapy targeting heat shock protein specific regulatory T cells in rheumatoid arthritis<br>12. T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis<br>13. Biomaterials as tools for re-balancing the skewed immunity in rheumatoid arthritis<br>14. Immunopathogenesis of systemic lupus erythematosus<br>15. Challenges in systemic lupus erythematosus: from bench to bedside<br>16. Therapeutic potential in systemic lupus erythematosus<br>17. The pathology and potential clinical applicability of interfering T cells in systemic lupus erythematosus<br>18. Rheumatic chorea<br>19. Management of the rheumatoid hind foot and ankle<br>20. Immunopathogenesis of scleroderma<br>21. Skin manifestations and autoimmune disturbances in dermatomyositis<br>22. T cells in systemic sclerosis<br>23. Etiopathogenesis of Behçet's disease: the role of genetic, immunological and environmental factors<br>24. Interleukin-1 family in Behçet's disease: inflammatory and anti-inflammatory mediators<br>25. Salivary gland regeneration and repair in Sjogren’s syndrome<br>26. Translational regulation of bone and joint inflammation by type 2 innate lymphoid cells<br>27. Arboviruses (Alphavirus) related to autoimmune rheumatic diseases: Triggers and possible therapeutic interventions<br>28. Rheumatologic manifestations of autoinflammatory disorders